Altogether, this data demonstrates that the 11 strains with non-inflammatory immunomodulatory activity enhance both ICI-mediated and spontaneous anti-tumor immunity in a CD8 T cell-dependent manner. The gene discussed is CD8A; the disease is neoplasm.